2366 studies found for:    electrocardiogram
Show Display Options
Rank Status Study
21 Completed Cardiac Disease and the Electrocardiogram in SCI Patients
Condition: Spinal Cord Injury
Intervention: Procedure: Cardiac Disease
22 Active, not recruiting Evaluation of a Non-Invasive Electrocardiogram-Assisted Blood Pressure Monitor
Conditions: Hypertension;   Atrial Fibrillation;   Obesity;   Heart Failure;   Atherosclerosis
Intervention:
23 Completed Evaluating Electrocardiogram (ECG) Abnormalities From Young Adulthood Through Middle Age
Condition: Cardiovascular Diseases
Intervention:
24 Unknown  Cerebral Artery Stenosis, Coronary Artery Disease and Arrhythmia
Conditions: Stroke;   Coronary Artery Disease;   Arrhythmia
Intervention: Procedure: Digital subtraction angiography and 24-hour simultaneous recorder of electrocardiograph
25 Recruiting A Study to Evaluate the Effects of JNJ-54861911 on Electrocardiogram Intervals in Healthy Particiants
Condition: Healthy
Interventions: Drug: JNJ-54861911-Therapeutic Dose;   Drug: JNJ-54861911 - Supratherapeutic Dose;   Drug: JNJ-54861911-Matched Placebo;   Drug: Moxifloxacin;   Drug: Moxifloxacin Matched Placebo
26 Not yet recruiting A Study to Evaluate the Effect of GSK1322322 on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers
Condition: Infections, Bacterial
Interventions: Drug: GSK1322322 1200 mg;   Drug: GSK1322322 3000 mg;   Drug: Placebo;   Drug: Moxifloxacin
27 Recruiting Home Electrocardiogram (ECG) Monitoring After Heart Transplantation
Conditions: Cardiac Transplant Rejection;   Qt Interval, Variation in
Intervention:
28 Completed TMC435-TiDP16-C117: The Effect of TMC435 on the Results of Electrocardiograms (Electric Recording of the Heart) in Healthy Volunteers
Condition: Hepatitis C
Interventions: Drug: TMC435;   Drug: Placebo for TMC435;   Drug: Moxifloxacin;   Drug: Placebo for moxifloxacin
29 Completed VX-950-TiDP24-C136 - A Trial to Evaluate the Effect of Telaprevir (TVR) on the Results of Electrocardiograms (Electric Recording of the Heart) in Healthy Volunteers
Condition: Hepatitis C
Intervention: Drug: Telaprevir; Moxifloxacin; Placebo
30 Completed ST- Depression on Electrocardiogram During Caesarean Section in Regional Anaesthesia in Women With Preeclampsia
Condition: Preeclampsia
Intervention: Drug: oxytocin
31 Completed A Study of the Effect of ASP1941 on Cardiac Repolarization in Healthy Subjects
Conditions: Healthy Subjects;   Cardiac Repolarization
Interventions: Drug: Placebo;   Drug: ASP1941;   Drug: Moxifloxacin
32 Unknown  Electrocardiography Versus Pulse Oximetry for Newborn Heart Rate Determination
Condition: Prematurity
Intervention: Device: Apparatuses
33 Unknown  Electrocardiogram Variations in the Prediction of Development of Atrial Fibrillation
Condition: Adults Past 18years Old With Two Electrocardiogram
Intervention:
34 Recruiting Fetal Electrocardiogram Extraction-Pilot Study
Condition: Pregnant Women
Intervention:
35 Terminated
Has Results
Electrocardiogram (ECG) Guided Peripherally Inserted Central Catheter (PICC) Placement
Condition: Placement of Peripherally Inserted Central Catheters (PICC)
Intervention: Device: ECG-guided PICC placement
36 Completed
Has Results
Feasibility and Acceptability of the Combination of Propess and AN24 Monica for Outpatient Labour Induction (PRAM)
Conditions: Intrapartum Fetal Monitoring;   Pregnancy
Interventions: Drug: Dinoprostone;   Device: Monica AN 24
37 Unknown  Time Frequency Analysis of Electrocardiogram and Blood Pressure in Intracranial Hemorrhage Patients
Conditions: Subarachnoid Hemorrhage;   Intracranial Hemorrhages;   Cerebral Hemorrhage
Intervention:
38 Completed Electrophysiological Effects of a Single 10 μg Dose of Exenatide on the 12-Lead Electrocardiogram QT Interval in Healthy Subjects
Condition: Healthy Subjects
Interventions: Drug: exenatide;   Drug: Moxifloxacin;   Drug: Placebo
39 Completed Study to Define the Electrocardiogram Effects of a Single Dose of LX4211 in Healthy Subjects
Condition: Healthy
Interventions: Drug: LX4211 800 mg;   Drug: LX4211 2000 mg;   Drug: moxifloxacin 400 mg;   Drug: LX4211 Placebo
40 Completed A Study to Evaluate the Effect of Oral Mirabegron on the Heart in Healthy Males and Females
Condition: Healthy Subjects
Interventions: Drug: Placebo;   Drug: mirabegron;   Drug: moxifloxacin

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years